Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 4/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | NT5E | P21589 | 3/20 | 0.54 |
| ▸ | NSD2 | O96028 | 3/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 2/20 | 0.46 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.46 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | PTPRC | P08575 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31398449 | 1.00 | CASP6 (0.68) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL31398448 | 1.00 | CASP6 (0.68) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL5292706 | 1.00 | CASP6 (0.68) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL22631256 | 0.89 | CASP6 (0.56) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL30675695 | 0.89 | CASP6 (0.56) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| Naphthalene Trisulfonate SCHEMBL306176 | 0.88 | CASP6 (0.58) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| Naphthalene Trisulfonate SCHEMBL29431498 | 0.88 | CASP6 (0.58) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| Naphthalene Trisulfonate SCHEMBL305166 | 0.88 | CASP6 (0.58) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL21854252 | 0.88 | CASP6 (0.54) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 | |
| Naphthalene Trisulfonate SCHEMBL23931196 | 0.86 | CASP6 (0.56) | CASP6HSD17B10ALDH1A1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053098-B1 | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORP (JP) | 2014-01-22 | — | — | EP | claimed |
| US-8100020-B2 | Compliant and wireless health monitoring sensors for composite structures | Lumimove, Inc., a Missouri Corporation (US) | 2012-01-24 | — | — | US | claimed |
| JP-2011525240-A | — | — | 2011-09-15 | — | — | JP | claimed |
| EP-2297559-A2 | COMPLIANT AND WIRELESS HEALTH MONITORING SENSORS FOR COMPOSITE STRUCTURES | Lumimove, Inc., Dba Crosslink (US) | 2011-03-23 | — | — | EP | claimed |
| CN-1831054-B | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORP | 2010-06-16 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-20100095781-A1 | COMPLIANT AND WIRELESS HEALTH MONITORING SENSORS FOR COMPOSITE STRUCTURES | LUMIMOVE, INC., D/B/A CROSSLINK (US) | 2010-04-22 | — | — | US | claimed |
| WO-2009155367-A2 | COMPLIANT AND WIRELESS HEALTH MONITORING SENSORS FOR COMPOSITE STRUCTURES | LUMIMOVE, INC., D/B/A CROSSLINK (US) | 2009-12-23 | — | — | WO | claimed |
| EP-2053098-A1 | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2009-04-29 | — | — | EP | claimed |
| EP-1700889-B1 | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORP (JP) | 2009-03-11 | — | — | EP | claimed |
| EP-1700889-A1 | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2006-09-13 | — | — | EP | claimed |
| CN-1831054-A | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORP (JP) | 2006-09-13 | — | — | CN | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6036833-A | PLATING WITH PERIODIC REVERSE PULSES AND A SULFONATED NAPHTHALENE ADDITIVE IN BATH CONTAINING NICKEL OR COBALT CHLORIDES AND/OR SULFATES YIELDS PLATINGS FREE OF INTERNAL STRESS | TANG PETER TORBEN (DK) | 2000-03-14 | — | — | US | claimed |
| EP-0820284-B1 | BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS | PHARMACIA & UPJOHN SPA (IT) | 2000-02-02 | — | — | EP | claimed |
| EP-0820284-A1 | BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS | PHARMACIA & UPJOHN S.p.A. (IT) | 1998-01-28 | — | — | EP | claimed |
| WO-1997028796-A1 | BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-08-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CASP6 2660/4885HSD17B10 2219/4885ALDH1A1 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.